Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.
暂无分享,去创建一个
Abhishek K. Jha | Thomas M. Wasylenko | Bryan T Mott | Clary B Clish | T. Jacks | M. V. Vander Heiden | C. Clish | Lucas B. Sullivan | Mark A Keibler | K. Pierce | Christopher R Chin | Shawn M Davidson | Dan Y. Gui | B. Mott | T. Papagiannakopoulos | B. Olenchock | Tyler Jacks | Thales Papagiannakopoulos | Matthew G Vander Heiden | M. R. Bauer | Lakshmi Subbaraj | Thomas M Wasylenko | Kerry A Pierce | Alba Luengo | Abhishek K Jha | Shawn M. Davidson | Matthew R. Bauer | Benjamin A Olenchock | Julia E Heyman | Alba Luengo | Matthew R Bauer | James P O'Brien | Dan Y Gui | Lucas B Sullivan | Lakshmipriya Subbaraj | Gregory Stephanopolous | Julia Heyman | Gregory Stephanopolous | James P. O’Brien | S. Davidson | M. Keibler | D. Y. Gui
[1] Kwok-Kin Wong,et al. Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. , 2010, Cell stem cell.
[2] Francisco J. Sánchez-Rivera,et al. Rapid modeling of cooperating genetic events in cancer through somatic genome editing , 2014, Nature.
[3] R. Deberardinis,et al. In vivo analysis of lung cancer metabolism: nothing like the real thing. , 2015, The Journal of clinical investigation.
[4] Eileen White,et al. Exploiting the bad eating habits of Ras-driven cancers , 2013, Genes & development.
[5] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[6] M. Stumvoll,et al. Role of glutamine in human carbohydrate metabolism in kidney and other tissues. , 1999, Kidney international.
[7] Mikko I. Kettunen,et al. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.
[8] Christian M. Metallo,et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.
[9] A. Lane,et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. , 2015, The Journal of clinical investigation.
[10] R. Deberardinis,et al. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells , 2011, Proceedings of the National Academy of Sciences.
[11] M. V. Vander Heiden,et al. METabolic adaptations in the tumor MYCroenvironment. , 2012, Cell metabolism.
[12] Sébastien Bonnet,et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. , 2007, Cancer cell.
[13] Ralph J DeBerardinis,et al. Glutamine and cancer: cell biology, physiology, and clinical opportunities. , 2013, The Journal of clinical investigation.
[14] W. Wheaton,et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.
[15] Russell G. Jones,et al. Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.
[16] R. Deberardinis,et al. Metabolism of [U‐13C]glucose in human brain tumors in vivo , 2012, NMR in biomedicine.
[17] A. Berns,et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.
[18] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.
[19] V. Gladyshev,et al. Age- and diet-associated metabolome remodeling characterizes the aging process driven by damage accumulation , 2014, eLife.
[20] Ralph Weissleder,et al. Effective Use of PI3K and MEK Inhibitors to Treat Mutant K-Ras G12D and PIK3CA H1047R Murine Lung Cancers , 2008, Nature Medicine.
[21] A. Fisher,et al. Intermediary metabolism of the lung. , 1984, Environmental health perspectives.
[22] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[23] T. Jacks,et al. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.
[24] Jie Li,et al. PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells , 2013, Cell.
[25] John Kurhanewicz,et al. Metabolic Reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor , 2013, The Prostate.
[26] David A. Eccles,et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. , 2015, Cell metabolism.
[27] M. V. Vander Heiden,et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. , 2015, Cancer research.
[28] L. Cantley,et al. Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance , 2013, Cell cycle.
[29] Jennifer B Dennison,et al. Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.
[30] J. Mackey,et al. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer , 2008, British Journal of Cancer.
[31] K. Bachman,et al. Analysis of glutamine dependency in non-small cell lung cancer , 2012, Cancer biology & therapy.
[32] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[33] R. Deberardinis,et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. , 2012, Cell metabolism.
[34] T. Fan,et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.
[35] T. Fan,et al. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM) , 2009, Molecular Cancer.
[36] Gregory J Morton,et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice , 2010, Disease Models & Mechanisms.
[37] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[38] R. DePinho,et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.
[39] A. Bassols,et al. Increased glucose transport in ras‐transformed fibroblasts: a possible role for N‐glycosylation of GLUT1 , 1997, FEBS letters.
[40] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[41] B. Faubert,et al. Metabolic Heterogeneity in Human Lung Tumors , 2016, Cell.
[42] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[43] M. V. Vander Heiden,et al. Famine versus feast: understanding the metabolism of tumors in vivo. , 2015, Trends in biochemical sciences.
[44] P. Bingham,et al. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo , 2011, Journal of Molecular Medicine.
[45] Peter Kraft,et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. , 2013, Clinical chemistry.
[46] Daniel B. Vigneron,et al. Validation of Hyperpolarized 13 C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor , 2012 .
[47] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[48] T. Jacks,et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.
[49] S. Lippman,et al. Lung cancer. , 2008, The New England journal of medicine.
[50] M. V. Heiden,et al. Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells , 2015, Cell.